MetaCap

Nanobiotix S.A. ADR (NBTX)

NASDAQ: NBTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.50-0.815 (-2.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NBTX stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.27
52-week range
19.14 – 57.14
Day range
26.12 – 28.15
Volume / Avg
125.28K / 148.94K
Beta
—

52-week range

$19.14$57.14

NBTX stock today

Nanobiotix S.A. (NBTX) closed at $26.50 on Nov 20, down 2.98% (-$0.815), versus the S&P 500's 3.70% decline. At this level, NBTX sits near the bottom of its 52-week range of $19.14 to $57.14: 53.6% below the high, set on May 14, 2026 and 38.5% above the low. NBTX is up 14.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.6%.

Nanobiotix S.A. has posted a net loss over the last twelve months (EPS of -$1.27), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Nanobiotix S.A.

Company profile

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Laurent Levy Ph.D.
Headquarters
Paris
Employees
98
IPO year
2020

Analyst forecast

Forecast

Consensus (5 analysts)

none

Avg. price target

$53.28+101.06%

  • Strong buy 0
  • Buy 4
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $29.53High $68.56

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

NBTX news

All NBTX news

Nanobiotix S.A. peers

Health Care sector
NBTX peer companies
CompanyPrice% ChgMarket capCompare
PAHCPhibro Animal Health Corporation Class A33.29-2.32%$1.35Bvs NBTX
URGNUroGen Pharma Ltd.27.65-12.86%$1.36Bvs NBTX
QUREuniQure N.V.19.35-4.35%$1.36Bvs NBTX
NUVBNuvation Bio Inc. Class A3.80-0.26%$1.34Bvs NBTX
RAPPRapport Therapeutics Inc.23.16-1.82%$1.37Bvs NBTX
ANABAnaptysBio Inc.46.63-1.62%$1.39Bvs NBTX
TYRATyra Biosciences Inc.20.12+1.98%$1.39Bvs NBTX
INVAInnoviva Inc.18.410.00%$1.31Bvs NBTX

Indexes, lists and sector

Nanobiotix S.A. stock FAQ

What is Nanobiotix S.A.'s stock price today?

NBTX last traded at $26.50 as of Nov 20, 4:00 PM EST, down 2.98% on the day. Prices are delayed at least 15 minutes.

Who is Nanobiotix S.A.'s CEO?

Dr. Laurent Levy Ph.D. is the chief executive officer of Nanobiotix S.A. ADR, which has about 98 employees.

What is the NBTX 52-week high?

The 52-week high for NBTX is $57.14 and the 52-week low is $19.14. The stock is currently 53.6% below its high.

Compare NBTX